Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG plus single-dose rifampicin for leprosy prevention in contacts
NL-OMON24868Not yet recruiting
- Sponsor
- Erasmus MC
- Start
- Oct 2011
- Modality
- Small Molecules, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Trial of bcg vaccine and rifampicin, sponsored by Erasmus MC. Planned start Oct 2011; status: not yet recruiting.
02
Drugs
bcg vaccinerifampicin
Beyond the preview
Go deeper on NL-OMON24868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24868.